Byakangelicin-d3
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
Byakangelicin-d3 Product Information
Byakangelicin-d3 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-101739.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Byakangelicin-d3
CAT No.
CS-T-101739
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H15D3O7
Molecular Weight
337.34
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
Byakangelicin-d3 is supplied with detailed characterization data compliant with regulatory guideline. Byakangelicin-d3 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"Byakangelicin-d3 is the labeled analog of Byakangelicin (B810680), an effective inhibitor of sex hormones and affects the catabolism of endogenous hormones. It directly affects the cytochrome P450 isoform (CY) P3A4 in human hepatocytes. Also, an inhibitor of aldose reductase and used in the treatment of diabetic cataract."
Synonyms
Byakangelicin-d3
Application Notes
"Byakangelicin-d3 is the labeled analog of Byakangelicin (B810680), an effective inhibitor of sex hormones and affects the catabolism of endogenous hormones. It directly affects the cytochrome P450 isoform (CY) P3A4 in human hepatocytes. Also, an inhibitor of aldose reductase and used in the treatment of diabetic cataract."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.